Skip to content
Back To Our Shop

Etanercept Drug Level ELISA (IDKmonitor®)

The innovative IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis.

Category:

Key Advantages

Highly specific assay, with no cross reactivity with infliximab, adalimumab or golimumab

Quick and reliable, with a total incubation time of 130 minutes

Gastroenterology and rheumatology applications

Reportable range 0.14-11.25 ug/ml

Easily automated on ELISA automates, such as the Dynex DS2

Determination of free therapeutic etanercept

The innovative IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. This test is intended to quantify the amount of free etanercept to evaluate its efficacy, as well as to investigate primary non-response, loss of response and non-remission, giving the treating clinician an opportunity to monitor and optimise therapy.

  • ELISA

  • 40 tests

  • Storage: 2-8 °C

  • Blood sample